Elephantiasis nostras verrucosa (ENV) is a rare and severe form of chroniclymphoedema. It leads to cutaneous changes including scarring, non-pittingoedema, hyperkeratosis, cobblestone-like papules, and induratedplaques on gravity-dependent body parts.
ENV predominantly affects the lower legs in a symmetrical fashion. Other sites that may be affected include the proximal thighs, abdomen, amputation stumps, and scrotum.
It is also known as lymphostatic verrucosis, elephantiasis crurum papillaris et verrucosa, ‘mossy leg’, lymphangitis recurrens elephantogenica, and lymphostatic papillomatosiscutis. ‘Nostras’ is a term used to describe the non-filiarial form of elephantiasis.
Gross hyperkeratosis and nodularity in ENV
Lymphoedema over the toes with overlying hyperkeratosis in ENV (ENV-patient2)
Close up of ENV - nodules, fibrosis and hyperkeratosis (ENV-patient2)
Ulceration over the medial malleolus with nodules, oedema, fibrosis and hyperkeratosis (ENV-patient1)
Elephantiasis nostras verrucosa is rare and can occur in males and females of all races.
It is associated with obesity and recurrentsoft tissueinfections. Other risk factors include malignancy, congestive heart failure, chronic venous insufficiency, previous trauma, hypothyroidism, and radiation.
What causes elephantiasis nostra verrucosa?
Elephantiasis nostras verrucosa is caused by chronic lymphostasis, which results in protein accumulation within the interstitial fluid, inducing fibroblastproliferation. This is thought to cause progressive fibrosis of the lymphatic drainage system, leading to obstruction. As the condition progresses, ulcers may develop, leading to recurrent secondary infection.
Conditions which cause impaired lymphatic drainage and can lead to ENV include:
How do clinical features vary in differing types of skin?
Striking white bright plaques and depigmentation have been reported in Fitzpatrick skin type VI. This is speculated to result from impaired melanogenesis due to chronic inflammation associated with lymphoedema.
What are the complications of elephantiasis nostra verrucosa?
Diagnosis is often made clinically, excluding other causes of lymphoedema on history and examination.
Patients often reveal a long history of oedema prior to the onset of fibrosis, hyperkeratosis, papules, and verrucous lesions. Recent travel, time course, and onset may differentiate from other causes such as filariasis.
Kaposi-Stemmer sign (an inability to pinch the skin overlying the base of the second toe) is indicative of lymphoedema.
Investigations
Bloods: full blood count, Giemsa-stained blood smear, and/or specific antigen testing may help rule out filariasis.
Biopsy may prove useful in excluding secondary malignancy but is often not necessary for diagnosis. Histology of ENV commonly shows acanthosis, papillomatosis, loss of adnexal structures, and progressive fibrosis.
Imaging studies such as CT, MRI, lymphoscintigraphy, and lymphangiography may prove useful in determining the degree and cause of lymphoedema.
What is the differential diagnosis for elephantiasis nostras verrucosa?
What is the treatment for elephantiasis nostras verrucosa?
Elephantiasis nostras verrucosa is difficult to treat with no known cure. The underlying cause should be treated to prevent further complications. Treatment of ENV can be conservative, medical, or surgical, depending on the severity and deformity.
Antibiotics — widely used in treating ENV, however, there is a lack of evidence for their efficacy in chronic infections
Antimicrobial preparations such as triclosan, acetic acid, and bleach baths — may prove useful in the prevention of secondary infections.
Surgical treatment
Surgical treatment may be indicated when fibrosis or nodules occur. Techniques of shaving, excision, and electrocauterisation can be used, however, the risk of scarring, infection, and non-healing ulcers should be considered.
Several case reports have found that ablativecarbon dioxide laser is well tolerated and provides cosmetic and symptomatic benefits to ENV patients.
How do you prevent elephantiasis nostras verrucosa?
Prevention of ENV relies on early management of lymphoedema through proper local hygiene, regular moisturiser, compression, lymphatic massage, weight loss, and exercise.
What is the outcome for elephantiasis nostras verrucosa?
Elephantiasis nostras verrucosa can result in progressive deformity of the limbs and reduced quality of life when the condition becomes debilitating.
Chawla S, Gan A, Ramakrishnan R, et al. Elephantiasis nostras verrucosa in skin of color. Int J Dermatol. 2022;61(2):e46-e47. doi: 10.1111/ijd.15907. Journal
Damstra RJ, Dickinson-Blok JL, Voesten HG. Shaving Technique and Compression Therapy for Elephantiasis Nostras Verrucosa (Lymphostatic Verrucosis) of Forefeet and Toes in End-Stage Primary Lymphedema: A 5 Year Follow-Up Study in 28 Patients and a Review of the Literature. J Clin Med. 2020;9(10):3139. doi: 10.3390/jcm9103139. Journal
Dean SM, Zirwas MJ, Horst AV. Elephantiasis nostras verrucosa: an institutional analysis of 21 cases. J Am Acad Dermatol. 2011;64(6):1104–1110. doi: 10.1016/j.jaad.2010.04.047. Journal
Fredman R, Tenenhaus M. Elephantiasis nostras verrucosa. Eplasty. 2012;12:ic14. Article
Gomez-Meade C, Combs A, Obed J, Skopit S. Elephantiasis Nostras Verrucosa: A case report. J Am Acad Dermatol. 2010;62(3). Journal
Kar Keong N, Siing Ngi AT, Muniandy P, Voon Fei W. Elephantiasis nostras verrucosa: a rare complication of lower limb lymphoedema. BMJ Case Rep. 2017;2017:bcr2017221492. doi: 10.1136/bcr-2017-221492. Journal
Liaw FY, Huang CF, Wu YC, Wu BY. Elephantiasis nostras verrucosa: swelling with verrucose appearance of lower limbs. Can Fam Physician. 2012;58(10):e551–e553. Journal
Moussa Y, Moussa M, Abou Chakra M. Penoscrotal Elephantiasis nostras verrucosa: A case report and literature review. Int J Surg Case Rep. 2019;65:127–130. doi: 10.1016/j.ijscr.2019.10.070. Journal
Sancho ADQ, Cura LRD, Alonso SA, López MAG. Treatment of Elephantiasis Nostras Verrucosa with CO2 Laser. Indian Dermatol Online J. 2019;10(6):704-706. doi: 10.4103/idoj.IDOJ_484_18. Journal
Sisto K, Khachemoune A. Elephantiasis nostras verrucosa: a review. Am J Clin Dermatol. 2008;9(3):141-146. doi: 10.2165/00128071-200809030-00001. Journal